## Core Concept
Carcinoembryonic antigen (CEA) is a tumor marker commonly used in clinical practice to monitor various types of cancers, particularly colorectal cancer. It is a glycoprotein present on the surface of certain cancer cells. Elevated levels of CEA can indicate recurrence or metastasis in cancer patients.

## Why the Correct Answer is Right
Option correctly identifies that CEA is not typically associated with one of the listed conditions. CEA is indeed linked to colorectal cancer, gastric cancer, and pancreatic cancer among others. However, its utility and elevation patterns vary across different cancer types.

## Why Each Wrong Option is Incorrect
* **Option A:** Colorectal cancer - CEA is indeed elevated in colorectal cancer and is used as a tumor marker for monitoring disease recurrence and response to treatment.
* **Option B:** Gastric cancer - CEA can be elevated in gastric cancer, although it is not as specific as other markers.
* **Option C:** Pancreatic cancer - CEA levels can be elevated in pancreatic cancer, and it is sometimes used in conjunction with CA 19-9 for diagnostic and monitoring purposes.

## Why Option D is Correct
* **Option D:** Prostate cancer - Prostate-specific antigen (PSA) is the primary tumor marker for prostate cancer, not CEA. CEA is not typically used for monitoring or diagnosing prostate cancer.

## Clinical Pearl / High-Yield Fact
A key clinical pearl is that while CEA is useful for monitoring disease recurrence and response to treatment in certain cancers, particularly colorectal cancer, its elevation can also be seen in non-malignant conditions such as smoking, inflammatory bowel disease, and liver disease. Therefore, CEA should be interpreted with caution and in the context of clinical presentation and imaging findings.

## Correct Answer: D. Prostate cancer